“genmab” Archives

in
Entry Author Date Location
AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase 09/04/20 National
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment 01/22/20 National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA 08/27/18 New York
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results 05/29/18 San Francisco
With $145M Buyout, River Vision’s Plan For Stalled Roche Drug Pays Off 05/08/17 New York
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal 07/05/16 New York
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Bio Venture Specialists Advent Raise $235M For European, U.S. Deals 10/28/14 National
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More 09/12/14 Seattle
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Life Science Discovery Fund Faces Cuts, Boeing’s Biofuel Push, SeaGen’s Latest Deal, & More Seattle-Area Life Sciences News 04/21/11 Seattle
Genmab Expands SeaGen Alliance 04/19/11 Seattle
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences 09/16/10 Seattle
Seattle Genetics Snags Genmab Deal 09/14/10 Seattle
Page 1 of 2 next page »